A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors.Rui‐Hua Xu, Joy Yan, Xiaoli Wei et al.|Journal of Clinical Oncology|2023Cited by 32
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trialXiuchun Chen, Zhenzhen Liu, Xianfu Sun et al.|The Lancet Oncology|2024Cited by 32
Upregulation of DLC‑1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer modelBo Chen, Ming Xu|Oncology Letters|2019Cited by 4
Role of blood-brain barrier leakage during strokeBo Chen|eScholarship (California Digital Library)|2010Cited by 0
MicroRNA-17-5p Downregulation Inhibits Autophagy and Myocardial Remodeling after Myocardial Infarction by Targeting STAT3Bo Chen, Jia Lü|Research Square|2021Cited by 0